EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1

Marius Zeeb iD, Katharina Kusejko, Sonja Hartnack, Chloé Pasin, Irene A Abela, Peter Rusert, Thomas Liechti, Claus Kadelka, Julia Notter, Anna Eichenberger, Matthias Hoffmann, Hans H Hirsch und 9 weitere

PLOS Pathogens · 13.08.2025 · 21 (8) · e1013350

DOI: 10.1371/journal.ppat.1013350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 13.08.2025. Verfasst von Marius Zeeb und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Swiss HIV Cohort Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Co-infection with Mycobacterium tuberculosis (MTB) differentially modulates untreated HIV-1 infection, with asymptomatic MTB reducing HIV-1 viremia and opportunistic infections and active tuberculosis (TB) accelerating AIDS progression. Here, we investigate antibody (Ab) responses to HIV-1 in people with HIV (PWH) without MTB, with asymptomatic MTB, and with later progression to active TB to elucidate MTB-associated effects on HIV-1 immune control.

Methods

Using the Swiss HIV Cohort Study (SHCS), we conducted a retrospective study that included 2,840 PWH with data on MTB status and HIV-1-specific plasma binding-/neutralizing-responses. We evaluated associations between MTB status and binding-/neutralizing-responses while adjusting for key disease and demographic parameters.

Results

Among the included 2,840 PWH, 263 PWH had asymptomatic MTB based on either a positive TST-/IGRA-test at the baseline (time of HIV-1 Ab measurement) or on later progression to active TB. Compared to PWH without MTB infection, PWH with asymptomatic MTB infection showed reduced HIV-1 Ab levels, both for Env binding (e.g., IgG1 BG505 trimer antigen, p = 0.024) and neutralization of a diverse panel of HIV-1 viruses (p = 0.012). Conversely, PWH (n = 32) who later progressed to active TB (>180 days after baseline) demonstrated a significant shift towards IgG3 in their HIV-1 Ab repertoire (p = 0.011), detectable in median 3.8 years (IQR 2.4 – 8.7) before active TB onset.

Conclusion

Our data indicate that asymptomatic MTB infection and active TB exert profound heterologous effects on HIV-1 specific Ab development. These findings advance our understanding of host-pathogen dynamics and may have implications for new diagnostic approaches in predicting future active TB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsMycobacterium tuberculosisTuberculosisHIV AntibodiesCoinfectionAntibody FormationHumansMaleFemaleRetrospective StudiesAdultMiddle Aged

Substanzen

HIV Antibodies

Autor:innen und Institutionen

  • Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Section of Epidemiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
  • Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital Sankt Gallen, St. Gallen, Switzerland.
  • Department of Infectious Diseases, Inselspital University Hospital Bern, Bern, Switzerland.
  • Clinic for Infectious Diseases, Olten Cantonal Hospital, Olten, Switzerland.

ORCID-Profile: Marius Zeeb

Förderung

  • Swiss National Science Foundation
  • Swiss HIV Cohort Research Foundation

Zitieren

APA

Zeeb, M., Kusejko, K., Hartnack, S., Pasin, C., Abela, I. A., Rusert, P., Liechti, T., Kadelka, C., Notter, J., Eichenberger, A., Hoffmann, M., Hirsch, H. H., Calmy, A., Cavassini, M., Labhardt, N. D., Bernasconi, E., Günthard, H. F., Kouyos, R. D., Trkola, A., …, & and the Swiss HIV Cohort Study (2025). Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1. PLOS Pathogens, 21(8), e1013350. https://doi.org/10.1371/journal.ppat.1013350

Vancouver

Zeeb M, Kusejko K, Hartnack S, Pasin C, Abela IA, Rusert P, et al. Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1. PLOS Pathogens. 2025;21(8):e1013350. doi:10.1371/journal.ppat.1013350

BibTeX
@article{Zeeb2025,
  author = {Zeeb, Marius and Kusejko, Katharina and Hartnack, Sonja and Pasin, Chloé and Abela, Irene A and Rusert, Peter and Liechti, Thomas and Kadelka, Claus and Notter, Julia and Eichenberger, Anna and Hoffmann, Matthias and Hirsch, Hans H and Calmy, Alexandra and Cavassini, Matthias and Labhardt, Niklaus D and Bernasconi, Enos and Günthard, Huldrych F and Kouyos, Roger D and Trkola, Alexandra and Nemeth, Johannes and and the Swiss HIV Cohort Study, and the Swiss HIV Cohort Study},
  title = {Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1},
  journal = {PLOS Pathogens},
  year = {2025},
  volume = {21},
  number = {8},
  pages = {e1013350},
  doi = {10.1371/journal.ppat.1013350}
}
Kostenlos starten →